InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Olema Pharmaceuticals, Inc.

OLMA Clue Score20
United States Fiscal year ends December CIK 0001750284 Results filed 10 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

11
Insider
Date
Role
Action
Shares
Price
Amount
Cyrus Harmon
24 Jul 2026
Director
Sell
12,500
$11.71
$146.43K
Cyrus Harmon
23 Jul 2026
Director
Sell
12,500
$11.58
$144.74K
Cyrus Harmon
20 Jan 2026
Director
Sell
10,000
$26.88
$268.80K
Shane William Charles Kovacs
15 Jan 2026
Ch. Operating & Financial Off.
Sell
100,000
$28.73
$2.87M
Cyrus Harmon
14 Jan 2026
Director
Sell
3,489
$29.12
$101.60K
Shane William Charles Kovacs
13 Jan 2026
Ch. Operating & Financial Off.
Sell
3,822
$28.01
$107.05K
David C. Myles
12 Jan 2026
Ch. Discov. & Non-Clin Dev Off
Sell indirect
10,000
$28.34
$283.40K
Cyrus Harmon
22 Dec 2025
Director
Sell
2,881
$28.53
$82.19K
David C. Myles
19 Dec 2025
Ch. Discov. & Non-Clin Dev Off
Sell
6,046
$31.39
$189.78K
David C. Myles
19 Dec 2025
Ch. Discov. & Non-Clin Dev Off
Sell
43,729
$30.40
$1.33M
David C. Myles
19 Dec 2025
Ch. Discov. & Non-Clin Dev Off
Sell
1,225
$28.08
$34.40K
Show all 26 transactions →

What was left out

Form 4 filings counted 32
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 14
Sales at will 11
Transactions with no price 0
Shares from compensation/vesting 945,736
History held since 19 Nov 2020